Industry Leaders

41. AI In Life Sciences — Seeing Past The Hype 3/1/2019

    Life science leaders must balance their need to apply AI technologies to improve patient care, and bottom lines — without getting caught-up in the AI hype machine.

42. Pitching Investors: It's About You, Not The Slide Deck 2/1/2019

    Let’s face it … pitching potential investors is a remarkable opportunity. It could be your one shot at getting your idea or company off the ground, so you better be appealing, tantalizing, and even provocative.

43. Beyond Capital and Mentoring: Paving The Way For Female Entrepreneurs 1/2/2019

    Women who are starting life sciences companies often do not have access to a network of mentors and advisors, whose strong advocacy establishes instant credibility and opens the doors to investors.

44. Why Soft Skills Are The Key To Better Science And Collaborations 8/2/2018

    Here are some examples of why “soft skills,” such as those related to relationship building, leadership, and communication, are essential to today’s pharma and biotech leaders.

45. As Pediatric Rare Disease Patients Grow Up, Can We Keep Pace? 8/2/2018

    Companies frequently talk about being patient-centric. But what I don’t hear discussed as often is the role of the patient after a drug is approved. And I am convinced it is equally important. Why? Because patients are not static; they grow and change over time.

46. Cell And Gene Therapies: Driving Innovation For Logistical Solutions 4/6/2018

    Aside from the clinical opportunity that gene therapy products present; they do introduce tremendous complexity into both the manufacturing and commercial processes. Remember these three points before developing your gene therapy plan.

47. Is Your Lab Prepared For A Cybersecurity Attack? 2/7/2018

    While the costs and reputational implications associated with pharma data breaches are enough to pay heed to cybersecurity, these compromises can pose a serious threat to patient safety.

48. Classifying Independent Contractors: 3 Things Pharma CEOs Should Know 1/9/2018

    Similar to a clinical trial setback, misclassification of independent contractors (ICs) can have a substantial negative impact on a pharma business.

49. In M&A, The Devil's In The Details ... Of Your Insurance Policy 1/9/2018

    Pharma companies that don’t emphasize risk management and insurance due diligence while adding exposures from new products or services to their policies will see the far-reaching impacts on their budgets.

50. Research Reveals Critical Need To Eliminate Clinical Silos 9/8/2017

    New research confirms that many of the challenges sponsors face managing clinical trials stem from the disparate nature of processes and systems.